TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Biosimilars Market
Global Biosimilars Market Research Report 2023

Global Biosimilars Market Research Report 2023

  • Category:Life Sciences
  • Published on : 28 December 2022
  • Pages :115
  • Formats:
  • Report Code:SMR-7522719
OfferClick for best price

Best Price: $2320

Biosimilars Market Size, Share 2022


Market Analysis and Insights: Global Biosimilars Market

The global Biosimilars market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biosimilars market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biosimilars market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biosimilars market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biosimilars market.

Global Biosimilars Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Segment by Application

  • Oncology

  • Blood Disorders

  • Growth Hormonal Deficiency

  • Chronic and Autoimmune Disorders

  • Others

By Region

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Asia-Pacific

  • China

  • Japan

  • South Korea

  • India

  • Australia

  • China Taiwan

  • Indonesia

  • Thailand

  • Malaysia

  • Latin America

  • Mexico

  • Brazil

  • Argentina

  • Middle East & Africa

  • Turkey

  • Saudi Arabia

  • UAE

By Company

  • Pfizer

  • Novartis

  • Biocon

  • Biogen

  • Fresenius Kabi AG

  • Boehringer Ingelheim

  • Merck KgaA

  • Mylan

  • Eli Lilly

  • Teva Pharmaceutical

  • Dr. Reddy's Laboratories

  • Amgen

  • Celltrion

  • Samsung Biologics

  • Roche

  • Probiomed

  • Apotex

  • Chong Kun Dang

  • JCR Pharmaceuticals

  • Gan & Lee Pharmaceuticals

  • Gedeon Richter

  • Biocad

  • Coherus Bioscience

  • Stada Arzneimittel AG

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Biosimilars product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Biosimilars, with price, sales, revenue, and global market share of Biosimilars from 2019 to 2022.

Chapter 3, the Biosimilars competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biosimilars market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Biosimilars.

Chapter 13, 14, and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Biosimilars Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Biosimilars Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 115 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Biosimilars Market Overview
1.1 Product Overview and Scope of Biosimilars
1.2 Biosimilars Segment by Type
1.2.1 Global Biosimilars Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.2.3 Recombinant Glycosylated Proteins
1.3 Biosimilars Segment by Application
1.3.1 Global Biosimilars Sales Comparison by Application: (2023-2030)
1.3.2 Oncology
1.3.3 Blood Disorders
1.3.4 Growth Hormonal Deficiency
1.3.5 Chronic and Autoimmune Disorders
1.3.6 Others
1.4 Global Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Biosimilars Revenue 2018-2030
1.4.2 Global Biosimilars Sales 2018-2030
1.4.3 Biosimilars Market Size by Region: 2018 Versus 2022 Versus 2030
2 Biosimilars Market Competition by Manufacturers
2.1 Global Biosimilars Sales Market Share by Manufacturers (2018-2023)
2.2 Global Biosimilars Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Biosimilars Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Biosimilars Manufacturing Sites, Area Served, Product Type
2.5 Biosimilars Market Competitive Situation and Trends
2.5.1 Biosimilars Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biosimilars Players Market Share by Revenue
2.5.3 Global Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biosimilars Retrospective Market Scenario by Region
3.1 Global Biosimilars Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Biosimilars Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Biosimilars Market Facts & Figures by Country
3.3.1 North America Biosimilars Sales by Country
3.3.2 North America Biosimilars Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biosimilars Market Facts & Figures by Country
3.4.1 Europe Biosimilars Sales by Country
3.4.2 Europe Biosimilars Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biosimilars Market Facts & Figures by Region
3.5.1 Asia Pacific Biosimilars Sales by Region
3.5.2 Asia Pacific Biosimilars Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biosimilars Market Facts & Figures by Country
3.6.1 Latin America Biosimilars Sales by Country
3.6.2 Latin America Biosimilars Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biosimilars Market Facts & Figures by Country
3.7.1 Middle East and Africa Biosimilars Sales by Country
3.7.2 Middle East and Africa Biosimilars Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biosimilars Historic Market Analysis by Type
4.1 Global Biosimilars Sales Market Share by Type (2018-2023)
4.2 Global Biosimilars Revenue Market Share by Type (2018-2023)
4.3 Global Biosimilars Price by Type (2018-2023)
5 Global Biosimilars Historic Market Analysis by Application
5.1 Global Biosimilars Sales Market Share by Application (2018-2023)
5.2 Global Biosimilars Revenue Market Share by Application (2018-2023)
5.3 Global Biosimilars Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Biosimilars Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Biosimilars Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Biocon Biosimilars Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biogen
6.4.1 Biogen Corporation Information
6.4.2 Biogen Description and Business Overview
6.4.3 Biogen Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biogen Biosimilars Product Portfolio
6.4.5 Biogen Recent Developments/Updates
6.5 Fresenius Kabi AG
6.5.1 Fresenius Kabi AG Corporation Information
6.5.2 Fresenius Kabi AG Description and Business Overview
6.5.3 Fresenius Kabi AG Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi AG Biosimilars Product Portfolio
6.5.5 Fresenius Kabi AG Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boehringer Ingelheim Biosimilars Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
6.7 Merck KgaA
6.6.1 Merck KgaA Corporation Information
6.6.2 Merck KgaA Description and Business Overview
6.6.3 Merck KgaA Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Merck KgaA Biosimilars Product Portfolio
6.7.5 Merck KgaA Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mylan Biosimilars Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Eli Lilly
6.9.1 Eli Lilly Corporation Information
6.9.2 Eli Lilly Description and Business Overview
6.9.3 Eli Lilly Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Eli Lilly Biosimilars Product Portfolio
6.9.5 Eli Lilly Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Corporation Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Pharmaceutical Biosimilars Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Dr. Reddy's Laboratories
6.11.1 Dr. Reddy's Laboratories Corporation Information
6.11.2 Dr. Reddy's Laboratories Biosimilars Description and Business Overview
6.11.3 Dr. Reddy's Laboratories Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Dr. Reddy's Laboratories Biosimilars Product Portfolio
6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.12 Amgen
6.12.1 Amgen Corporation Information
6.12.2 Amgen Biosimilars Description and Business Overview
6.12.3 Amgen Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Amgen Biosimilars Product Portfolio
6.12.5 Amgen Recent Developments/Updates
6.13 Celltrion
6.13.1 Celltrion Corporation Information
6.13.2 Celltrion Biosimilars Description and Business Overview
6.13.3 Celltrion Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Celltrion Biosimilars Product Portfolio
6.13.5 Celltrion Recent Developments/Updates
6.14 Samsung Biologics
6.14.1 Samsung Biologics Corporation Information
6.14.2 Samsung Biologics Biosimilars Description and Business Overview
6.14.3 Samsung Biologics Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Samsung Biologics Biosimilars Product Portfolio
6.14.5 Samsung Biologics Recent Developments/Updates
6.15 Roche
6.15.1 Roche Corporation Information
6.15.2 Roche Biosimilars Description and Business Overview
6.15.3 Roche Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Roche Biosimilars Product Portfolio
6.15.5 Roche Recent Developments/Updates
6.16 Probiomed
6.16.1 Probiomed Corporation Information
6.16.2 Probiomed Biosimilars Description and Business Overview
6.16.3 Probiomed Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Probiomed Biosimilars Product Portfolio
6.16.5 Probiomed Recent Developments/Updates
6.17 Apotex
6.17.1 Apotex Corporation Information
6.17.2 Apotex Biosimilars Description and Business Overview
6.17.3 Apotex Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Apotex Biosimilars Product Portfolio
6.17.5 Apotex Recent Developments/Updates
6.18 Chong Kun Dang
6.18.1 Chong Kun Dang Corporation Information
6.18.2 Chong Kun Dang Biosimilars Description and Business Overview
6.18.3 Chong Kun Dang Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Chong Kun Dang Biosimilars Product Portfolio
6.18.5 Chong Kun Dang Recent Developments/Updates
6.19 JCR Pharmaceuticals
6.19.1 JCR Pharmaceuticals Corporation Information
6.19.2 JCR Pharmaceuticals Biosimilars Description and Business Overview
6.19.3 JCR Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.19.4 JCR Pharmaceuticals Biosimilars Product Portfolio
6.19.5 JCR Pharmaceuticals Recent Developments/Updates
6.20 Gan & Lee Pharmaceuticals
6.20.1 Gan & Lee Pharmaceuticals Corporation Information
6.20.2 Gan & Lee Pharmaceuticals Biosimilars Description and Business Overview
6.20.3 Gan & Lee Pharmaceuticals Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Gan & Lee Pharmaceuticals Biosimilars Product Portfolio
6.20.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.21 Gedeon Richter
6.21.1 Gedeon Richter Corporation Information
6.21.2 Gedeon Richter Biosimilars Description and Business Overview
6.21.3 Gedeon Richter Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Gedeon Richter Biosimilars Product Portfolio
6.21.5 Gedeon Richter Recent Developments/Updates
6.22 Biocad
6.22.1 Biocad Corporation Information
6.22.2 Biocad Biosimilars Description and Business Overview
6.22.3 Biocad Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Biocad Biosimilars Product Portfolio
6.22.5 Biocad Recent Developments/Updates
6.23 Coherus Bioscience
6.23.1 Coherus Bioscience Corporation Information
6.23.2 Coherus Bioscience Biosimilars Description and Business Overview
6.23.3 Coherus Bioscience Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Coherus Bioscience Biosimilars Product Portfolio
6.23.5 Coherus Bioscience Recent Developments/Updates
6.24 Stada Arzneimittel AG
6.24.1 Stada Arzneimittel AG Corporation Information
6.24.2 Stada Arzneimittel AG Biosimilars Description and Business Overview
6.24.3 Stada Arzneimittel AG Biosimilars Sales, Revenue and Gross Margin (2018-2023)
6.24.4 Stada Arzneimittel AG Biosimilars Product Portfolio
6.24.5 Stada Arzneimittel AG Recent Developments/Updates
7 Biosimilars Manufacturing Cost Analysis
7.1 Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biosimilars
7.4 Biosimilars Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biosimilars Distributors List
8.3 Biosimilars Customers
9 Biosimilars Market Dynamics
9.1 Biosimilars Industry Trends
9.2 Biosimilars Market Drivers
9.3 Biosimilars Market Challenges
9.4 Biosimilars Market Restraints
10 Global Market Forecast
10.1 Biosimilars Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biosimilars by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Biosimilars by Type (2023-2030)
10.2 Biosimilars Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biosimilars by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Biosimilars by Application (2023-2030)
10.3 Biosimilars Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biosimilars by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Biosimilars by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Biosimilars Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Biosimilars Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Biosimilars Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Biosimilars Market Competitive Situation by Manufacturers in 2022
Table 5. Global Biosimilars Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Biosimilars Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Biosimilars Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Biosimilars Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Biosimilars Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Biosimilars Manufacturing Sites and Area Served
Table 11. Manufacturers Biosimilars Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biosimilars Sales by Region (2018-2023) & (K Units)
Table 16. Global Biosimilars Sales Market Share by Region (2018-2023)
Table 17. Global Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Biosimilars Revenue Market Share by Region (2018-2023)
Table 19. North America Biosimilars Sales by Country (2018-2023) & (K Units)
Table 20. North America Biosimilars Sales Market Share by Country (2018-2023)
Table 21. North America Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Biosimilars Revenue Market Share by Country (2018-2023)
Table 23. Europe Biosimilars Sales by Country (2018-2023) & (K Units)
Table 24. Europe Biosimilars Sales Market Share by Country (2018-2023)
Table 25. Europe Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Biosimilars Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Biosimilars Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Biosimilars Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Biosimilars Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Biosimilars Revenue Market Share by Region (2018-2023)
Table 31. Latin America Biosimilars Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Biosimilars Sales Market Share by Country (2018-2023)
Table 33. Latin America Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Biosimilars Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Biosimilars Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Biosimilars Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Biosimilars Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Biosimilars Revenue Market Share by Country (2018-2023)
Table 39. Global Biosimilars Sales by Type (2018-2023) & (K Units)
Table 40. Global Biosimilars Sales Market Share by Type (2018-2023)
Table 41. Global Biosimilars Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Biosimilars Revenue Share by Type (2018-2023)
Table 43. Global Biosimilars Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Biosimilars Sales (K Units) by Application (2018-2023)
Table 45. Global Biosimilars Sales Market Share by Application (2018-2023)
Table 46. Global Biosimilars Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Biosimilars Revenue Share by Application (2018-2023)
Table 48. Global Biosimilars Price by Application (2018-2023) & (USD/Unit)
Table 49. Pfizer Corporation Information
Table 50. Pfizer Description and Business Overview
Table 51. Pfizer Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Pfizer Biosimilars Product
Table 53. Pfizer Recent Developments/Updates
Table 54. Novartis Corporation Information
Table 55. Novartis Description and Business Overview
Table 56. Novartis Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Novartis Biosimilars Product
Table 58. Novartis Recent Developments/Updates
Table 59. Biocon Corporation Information
Table 60. Biocon Description and Business Overview
Table 61. Biocon Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Biocon Biosimilars Product
Table 63. Biocon Recent Developments/Updates
Table 64. Biogen Corporation Information
Table 65. Biogen Description and Business Overview
Table 66. Biogen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Biogen Biosimilars Product
Table 68. Biogen Recent Developments/Updates
Table 69. Fresenius Kabi AG Corporation Information
Table 70. Fresenius Kabi AG Description and Business Overview
Table 71. Fresenius Kabi AG Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Fresenius Kabi AG Biosimilars Product
Table 73. Fresenius Kabi AG Recent Developments/Updates
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Description and Business Overview
Table 76. Boehringer Ingelheim Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Boehringer Ingelheim Biosimilars Product
Table 78. Boehringer Ingelheim Recent Developments/Updates
Table 79. Merck KgaA Corporation Information
Table 80. Merck KgaA Description and Business Overview
Table 81. Merck KgaA Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Merck KgaA Biosimilars Product
Table 83. Merck KgaA Recent Developments/Updates
Table 84. Mylan Corporation Information
Table 85. Mylan Description and Business Overview
Table 86. Mylan Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Mylan Biosimilars Product
Table 88. Mylan Recent Developments/Updates
Table 89. Eli Lilly Corporation Information
Table 90. Eli Lilly Description and Business Overview
Table 91. Eli Lilly Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Eli Lilly Biosimilars Product
Table 93. Eli Lilly Recent Developments/Updates
Table 94. Teva Pharmaceutical Corporation Information
Table 95. Teva Pharmaceutical Description and Business Overview
Table 96. Teva Pharmaceutical Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Teva Pharmaceutical Biosimilars Product
Table 98. Teva Pharmaceutical Recent Developments/Updates
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Description and Business Overview
Table 101. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Dr. Reddy's Laboratories Biosimilars Product
Table 103. Dr. Reddy's Laboratories Recent Developments/Updates
Table 104. Amgen Corporation Information
Table 105. Amgen Description and Business Overview
Table 106. Amgen Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Amgen Biosimilars Product
Table 108. Amgen Recent Developments/Updates
Table 109. Celltrion Corporation Information
Table 110. Celltrion Description and Business Overview
Table 111. Celltrion Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Celltrion Biosimilars Product
Table 113. Celltrion Recent Developments/Updates
Table 114. Samsung Biologics Corporation Information
Table 115. Samsung Biologics Description and Business Overview
Table 116. Samsung Biologics Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Samsung Biologics Biosimilars Product
Table 118. Samsung Biologics Recent Developments/Updates
Table 119. Roche Corporation Information
Table 120. Roche Description and Business Overview
Table 121. Roche Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Roche Biosimilars Product
Table 123. Roche Recent Developments/Updates
Table 124. Probiomed Corporation Information
Table 125. Probiomed Description and Business Overview
Table 126. Probiomed Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Probiomed Biosimilars Product
Table 128. Probiomed Recent Developments/Updates
Table 129. Apotex Corporation Information
Table 130. Apotex Description and Business Overview
Table 131. Apotex Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Apotex Biosimilars Product
Table 133. Apotex Recent Developments/Updates
Table 134. Chong Kun Dang Corporation Information
Table 135. Chong Kun Dang Description and Business Overview
Table 136. Chong Kun Dang Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Chong Kun Dang Biosimilars Product
Table 138. Chong Kun Dang Recent Developments/Updates
Table 139. JCR Pharmaceuticals Corporation Information
Table 140. JCR Pharmaceuticals Description and Business Overview
Table 141. JCR Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. JCR Pharmaceuticals Biosimilars Product
Table 143. JCR Pharmaceuticals Recent Developments/Updates
Table 144. Gan & Lee Pharmaceuticals Corporation Information
Table 145. Gan & Lee Pharmaceuticals Description and Business Overview
Table 146. Gan & Lee Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Gan & Lee Pharmaceuticals Biosimilars Product
Table 148. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 149. Gedeon Richter Corporation Information
Table 150. Gedeon Richter Description and Business Overview
Table 151. Gedeon Richter Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Gedeon Richter Biosimilars Product
Table 153. Gedeon Richter Recent Developments/Updates
Table 154. Biocad Corporation Information
Table 155. Biocad Description and Business Overview
Table 156. Biocad Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. Biocad Biosimilars Product
Table 158. Biocad Recent Developments/Updates
Table 159. Coherus Bioscience Corporation Information
Table 160. Coherus Bioscience Description and Business Overview
Table 161. Coherus Bioscience Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. Coherus Bioscience Biosimilars Product
Table 163. Coherus Bioscience Recent Developments/Updates
Table 164. Stada Arzneimittel AG Corporation Information
Table 165. Stada Arzneimittel AG Description and Business Overview
Table 166. Stada Arzneimittel AG Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. Stada Arzneimittel AG Biosimilars Product
Table 168. Stada Arzneimittel AG Recent Developments/Updates
Table 169. Production Base and Market Concentration Rate of Raw Material
Table 170. Key Suppliers of Raw Materials
Table 171. Biosimilars Distributors List
Table 172. Biosimilars Customers List
Table 173. Biosimilars Market Trends
Table 174. Biosimilars Market Drivers
Table 175. Biosimilars Market Challenges
Table 176. Biosimilars Market Restraints
Table 177. Global Biosimilars Sales Forecast by Type (2023-2030) & (K Units)
Table 178. Global Biosimilars Sales Market Share Forecast by Type (2023-2030)
Table 179. Global Biosimilars Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 180. Global Biosimilars Revenue Market Share Forecast by Type (2023-2030)
Table 181. Global Biosimilars Sales Forecast by Application (2023-2030) & (K Units)
Table 182. Global Biosimilars Sales Market Share Forecast by Application (2023-2030)
Table 183. Global Biosimilars Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 184. Global Biosimilars Revenue Market Share Forecast by Application (2023-2030)
Table 185. Global Biosimilars Sales Forecast by Region (2023-2030) & (K Units)
Table 186. Global Biosimilars Sales Market Share Forecast by Region (2023-2030)
Table 187. Global Biosimilars Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 188. Global Biosimilars Revenue Market Share Forecast by Region (2023-2030)
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biosimilars
Figure 2. Global Biosimilars Market Share by Type in 2022 & 2030
Figure 3. Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Product Picture
Figure 4. Recombinant Glycosylated Proteins Product Picture
Figure 5. Global Biosimilars Market Share by Application in 2022 & 2030
Figure 6. Oncology
Figure 7. Blood Disorders
Figure 8. Growth Hormonal Deficiency
Figure 9. Chronic and Autoimmune Disorders
Figure 10. Others
Figure 11. Global Biosimilars Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 12. Global Biosimilars Market Size (2018-2030) & (US$ Million)
Figure 13. Global Biosimilars Sales (2018-2030) & (K Units)
Figure 14. Biosimilars Sales Share by Manufacturers in 2022
Figure 15. Global Biosimilars Revenue Share by Manufacturers in 2022
Figure 16. The Global 5 and 10 Largest Biosimilars Players: Market Share by Revenue in 2022
Figure 17. Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 18. Global Biosimilars Sales Market Share by Region (2018-2023)
Figure 19. Global Biosimilars Sales Market Share by Region in 2022
Figure 20. Global Biosimilars Revenue Market Share by Region (2018-2023)
Figure 21. Global Biosimilars Revenue Market Share by Region in 2022
Figure 22. U.S. Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Canada Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. Germany Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. France Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. U.K. Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Italy Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Russia Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. China Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. Japan Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. South Korea Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. India Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Australia Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. China Taiwan Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Indonesia Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Thailand Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Malaysia Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Mexico Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Brazil Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Argentina Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Turkey Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Saudi Arabia Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. UAE Biosimilars Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Sales Market Share of Biosimilars by Type (2018-2023)
Figure 45. Manufacturing Cost Structure of Biosimilars
Figure 46. Manufacturing Process Analysis of Biosimilars
Figure 47. Biosimilars Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount